Header Logo

Connection

PETER HOTEZ to Animals

Back to Details
This is a "connection" page, showing publications PETER HOTEZ has written about Animals.
PETER HOTEZ
Connection Strength
3.660
Animals
  1. Vaccines in a time of global boiling and megacities. Trends Parasitol. 2025 Mar; 41(3):167-169.
    View in: PubMed
    Score: 0.052
  2. The zebrafish as a potential model for vaccine and adjuvant development. Expert Rev Vaccines. 2024 Jan-Dec; 23(1):535-545.
    View in: PubMed
    Score: 0.049
  3. Vaccine value profile for Hookworm. Vaccine. 2024 07 25; 42(19 Suppl 1):S25-S41.
    View in: PubMed
    Score: 0.048
  4. Neglected tropical disease vaccines: hookworm, leishmaniasis, and schistosomiasis. Vaccine. 2023 11 03; 41 Suppl 2:S176-S179.
    View in: PubMed
    Score: 0.047
  5. Vaccine-linked chemotherapy improves cardiac structure and function in a mouse model of chronic Chagas disease. Front Cell Infect Microbiol. 2023; 13:1106315.
    View in: PubMed
    Score: 0.045
  6. Mucosal Vaccination With Recombinant Tm-WAP49 Protein Induces Protective Humoral and Cellular Immunity Against Experimental Trichuriasis in AKR Mice. Front Immunol. 2022; 13:800295.
    View in: PubMed
    Score: 0.042
  7. The yin and yang of human soil-transmitted helminth infections. Int J Parasitol. 2021 12; 51(13-14):1243-1253.
    View in: PubMed
    Score: 0.042
  8. Whole Inactivated Virus and Protein-Based COVID-19 Vaccines. Annu Rev Med. 2022 01 27; 73:55-64.
    View in: PubMed
    Score: 0.041
  9. NTDs in the 2020s: An epic struggle of effective control tools versus the Anthropocene. PLoS Negl Trop Dis. 2020 09; 14(9):e0007872.
    View in: PubMed
    Score: 0.038
  10. Developing a low-cost and accessible COVID-19 vaccine for global health. PLoS Negl Trop Dis. 2020 07; 14(7):e0008548.
    View in: PubMed
    Score: 0.038
  11. COVID-19 vaccines: neutralizing antibodies and the alum advantage. Nat Rev Immunol. 2020 07; 20(7):399-400.
    View in: PubMed
    Score: 0.038
  12. COVID-19 vaccine design: the Janus face of immune enhancement. Nat Rev Immunol. 2020 06; 20(6):347-348.
    View in: PubMed
    Score: 0.037
  13. Toxocariasis: A neglected infection for the Anthropocene epoch. Adv Parasitol. 2020; 109:879-883.
    View in: PubMed
    Score: 0.037
  14. Female Genital Schistosomiasis. N Engl J Med. 2019 Dec 26; 381(26):2493-2495.
    View in: PubMed
    Score: 0.037
  15. Female genital schistosomiasis and HIV/AIDS: Reversing the neglect of girls and women. PLoS Negl Trop Dis. 2019 04; 13(4):e0007025.
    View in: PubMed
    Score: 0.035
  16. Resolving "worm wars": An extended comparison review of findings from key economics and epidemiological studies. PLoS Negl Trop Dis. 2019 03; 13(3):e0006940.
    View in: PubMed
    Score: 0.035
  17. Ghana: Accelerating neglected tropical disease control in a setting of economic development. PLoS Negl Trop Dis. 2019 01; 13(1):e0007005.
    View in: PubMed
    Score: 0.034
  18. Trichuris muris whey acidic protein induces type 2 protective immunity against whipworm. PLoS Pathog. 2018 08; 14(8):e1007273.
    View in: PubMed
    Score: 0.033
  19. Hajj, Umrah, and the neglected tropical diseases. PLoS Negl Trop Dis. 2018 08; 12(8):e0006539.
    View in: PubMed
    Score: 0.033
  20. Global "worming": Climate change and its projected general impact on human helminth infections. PLoS Negl Trop Dis. 2018 07; 12(7):e0006370.
    View in: PubMed
    Score: 0.033
  21. Human Parasitology and Parasitic Diseases: Heading Towards 2050. Adv Parasitol. 2018; 100:29-38.
    View in: PubMed
    Score: 0.032
  22. Engineering a stable CHO cell line for the expression of a MERS-coronavirus vaccine antigen. Vaccine. 2018 03 27; 36(14):1853-1862.
    View in: PubMed
    Score: 0.032
  23. The rise of neglected tropical diseases in the "new Texas". PLoS Negl Trop Dis. 2018 01; 12(1):e0005581.
    View in: PubMed
    Score: 0.032
  24. Empowering Girls and Women through Hookworm Prevention. Am J Trop Med Hyg. 2018 05; 98(5):1211-1212.
    View in: PubMed
    Score: 0.032
  25. Venezuela and its rising vector-borne neglected diseases. PLoS Negl Trop Dis. 2017 Jun; 11(6):e0005423.
    View in: PubMed
    Score: 0.031
  26. PLOS Neglected Tropical Diseases: Ten years of progress in neglected tropical disease control and elimination ? More or less. PLoS Negl Trop Dis. 2017 04; 11(4):e0005355.
    View in: PubMed
    Score: 0.030
  27. Cysteine mutagenesis improves the production without abrogating antigenicity of a recombinant protein vaccine candidate for human chagas disease. Hum Vaccin Immunother. 2017 03 04; 13(3):621-633.
    View in: PubMed
    Score: 0.029
  28. The Hygiene Hypothesis and Its Inconvenient Truths about Helminth Infections. PLoS Negl Trop Dis. 2016 09; 10(9):e0004944.
    View in: PubMed
    Score: 0.029
  29. Southern Europe's Coming Plagues: Vector-Borne Neglected Tropical Diseases. PLoS Negl Trop Dis. 2016 06; 10(6):e0004243.
    View in: PubMed
    Score: 0.029
  30. Zika in the United States of America and a Fateful 1969 Decision. PLoS Negl Trop Dis. 2016 05; 10(5):e0004765.
    View in: PubMed
    Score: 0.028
  31. Advancing a vaccine to prevent hookworm disease and anemia. Vaccine. 2016 06 03; 34(26):3001-3005.
    View in: PubMed
    Score: 0.028
  32. Eliminating the Neglected Tropical Diseases: Translational Science and New Technologies. PLoS Negl Trop Dis. 2016 Mar; 10(3):e0003895.
    View in: PubMed
    Score: 0.028
  33. The 1899 United States Kissing Bug Epidemic. PLoS Negl Trop Dis. 2015 Dec; 9(12):e0004117.
    View in: PubMed
    Score: 0.028
  34. Neglected tropical diseases among the Association of Southeast Asian Nations (ASEAN): overview and update. PLoS Negl Trop Dis. 2015 Apr; 9(4):e0003575.
    View in: PubMed
    Score: 0.026
  35. The medical biochemistry of poverty and neglect. Mol Med. 2014 Dec 16; 20 Suppl 1:S31-6.
    View in: PubMed
    Score: 0.026
  36. Calling for rapid development of a safe and effective MERS vaccine. Microbes Infect. 2014 Jul; 16(7):529-31.
    View in: PubMed
    Score: 0.025
  37. The Gulf Coast: a new American underbelly of tropical diseases and poverty. PLoS Negl Trop Dis. 2014 May; 8(5):e2760.
    View in: PubMed
    Score: 0.025
  38. Advancing a multivalent 'Pan-anthelmintic' vaccine against soil-transmitted nematode infections. Expert Rev Vaccines. 2014 Mar; 13(3):321-31.
    View in: PubMed
    Score: 0.024
  39. The undernourished neonatal mouse metabolome reveals evidence of liver and biliary dysfunction, inflammation, and oxidative stress. J Nutr. 2014 Mar; 144(3):273-81.
    View in: PubMed
    Score: 0.024
  40. The Human Hookworm Vaccine. Vaccine. 2013 Apr 18; 31 Suppl 2:B227-32.
    View in: PubMed
    Score: 0.023
  41. Break Out: urogenital schistosomiasis and Schistosoma haematobium infection in the post-genomic era. PLoS Negl Trop Dis. 2013; 7(3):e1961.
    View in: PubMed
    Score: 0.023
  42. Roadmap to developing a recombinant coronavirus S protein receptor-binding domain vaccine for severe acute respiratory syndrome. Expert Rev Vaccines. 2012 Dec; 11(12):1405-13.
    View in: PubMed
    Score: 0.022
  43. Neglected tropical diseases of the Middle East and North Africa: review of their prevalence, distribution, and opportunities for control. PLoS Negl Trop Dis. 2012; 6(2):e1475.
    View in: PubMed
    Score: 0.021
  44. Neglected tropical diseases and the 2012 US presidential election. PLoS Negl Trop Dis. 2011 Nov; 5(11):e1431.
    View in: PubMed
    Score: 0.021
  45. The neglected tropical diseases of India and South Asia: review of their prevalence, distribution, and control or elimination. PLoS Negl Trop Dis. 2011 Oct; 5(10):e1222.
    View in: PubMed
    Score: 0.021
  46. Central Asia's hidden burden of neglected tropical diseases. PLoS Negl Trop Dis. 2011 Sep; 5(9):e1224.
    View in: PubMed
    Score: 0.021
  47. Vaccinomics for the major blood feeding helminths of humans. OMICS. 2011 Sep; 15(9):567-77.
    View in: PubMed
    Score: 0.020
  48. Ac-AP-12, a novel factor Xa anticoagulant peptide from the esophageal glands of adult Ancylostoma caninum. Mol Biochem Parasitol. 2011 May; 177(1):42-8.
    View in: PubMed
    Score: 0.020
  49. Vaccines to combat the neglected tropical diseases. Immunol Rev. 2011 Jan; 239(1):237-70.
    View in: PubMed
    Score: 0.020
  50. Developing vaccines to combat hookworm infection and intestinal schistosomiasis. Nat Rev Microbiol. 2010 Nov; 8(11):814-26.
    View in: PubMed
    Score: 0.019
  51. Molecular cloning, biochemical characterization, and partial protective immunity of the heme-binding glutathione S-transferases from the human hookworm Necator americanus. Infect Immun. 2010 Apr; 78(4):1552-63.
    View in: PubMed
    Score: 0.018
  52. Crystallization and preliminary X-ray analysis of Na-SAA-2 from the human hookworm parasite Necator americanus. Acta Crystallogr Sect F Struct Biol Cryst Commun. 2010 Feb 01; 66(Pt 2):172-6.
    View in: PubMed
    Score: 0.018
  53. Escalating the global fight against neglected tropical diseases through interventions in the Asia Pacific region. Adv Parasitol. 2010; 72:31-53.
    View in: PubMed
    Score: 0.018
  54. Rescuing the bottom billion through control of neglected tropical diseases. Lancet. 2009 May 02; 373(9674):1570-5.
    View in: PubMed
    Score: 0.017
  55. Toxocariasis: America's most common neglected infection of poverty and a helminthiasis of global importance? PLoS Negl Trop Dis. 2009; 3(3):e400.
    View in: PubMed
    Score: 0.017
  56. Molecular cloning and characterization of Ac-TMP-2, a tissue inhibitor of metalloproteinase secreted by adult Ancylostoma caninum. Mol Biochem Parasitol. 2008 Dec; 162(2):142-8.
    View in: PubMed
    Score: 0.017
  57. Multivalent anthelminthic vaccine to prevent hookworm and schistosomiasis. Expert Rev Vaccines. 2008 Aug; 7(6):745-52.
    View in: PubMed
    Score: 0.017
  58. Tropical anemia: one of Africa's great killers and a rationale for linking malaria and neglected tropical disease control to achieve a common goal. PLoS Negl Trop Dis. 2008 Jul 30; 2(7):e270.
    View in: PubMed
    Score: 0.017
  59. Holidays in the sun and the Caribbean's forgotten burden of neglected tropical diseases. PLoS Negl Trop Dis. 2008 May 28; 2(5):e239.
    View in: PubMed
    Score: 0.016
  60. Helminth infections: the great neglected tropical diseases. J Clin Invest. 2008 Apr; 118(4):1311-21.
    View in: PubMed
    Score: 0.016
  61. Randomized, placebo-controlled, double-blind trial of the Na-ASP-2 hookworm vaccine in unexposed adults. Vaccine. 2008 May 02; 26(19):2408-17.
    View in: PubMed
    Score: 0.016
  62. The giant anteater in the room: Brazil's neglected tropical diseases problem. PLoS Negl Trop Dis. 2008 Jan 30; 2(1):e177.
    View in: PubMed
    Score: 0.016
  63. Hookworm vaccines. Clin Infect Dis. 2008 Jan 15; 46(2):282-8.
    View in: PubMed
    Score: 0.016
  64. Use of the air pouch model to investigate immune responses to a hookworm vaccine containing the Na-ASP-2 protein in rats. Parasite Immunol. 2008 Jan; 30(1):53-6.
    View in: PubMed
    Score: 0.016
  65. X-ray structures of Na-GST-1 and Na-GST-2 two glutathione S-transferase from the human hookworm Necator americanus. BMC Struct Biol. 2007 Jun 26; 7:42.
    View in: PubMed
    Score: 0.015
  66. Control of onchocerciasis--the next generation. Lancet. 2007 Jun 16; 369(9578):1979-1980.
    View in: PubMed
    Score: 0.015
  67. The evaluation of recombinant hookworm antigens as vaccines in hamsters (Mesocricetus auratus) challenged with human hookworm, Necator americanus. Exp Parasitol. 2008 Jan; 118(1):32-40.
    View in: PubMed
    Score: 0.015
  68. Molecular cloning and characterization of Ac-MTP-2, an astacin-like metalloprotease released by adult Ancylostoma caninum. Mol Biochem Parasitol. 2007 Apr; 152(2):132-8.
    View in: PubMed
    Score: 0.015
  69. New technologies for the control of human hookworm infection. Trends Parasitol. 2006 Jul; 22(7):327-31.
    View in: PubMed
    Score: 0.014
  70. Soil-transmitted helminth infections: ascariasis, trichuriasis, and hookworm. Lancet. 2006 May 06; 367(9521):1521-32.
    View in: PubMed
    Score: 0.014
  71. Immunotherapy of TSA-1.C4 or in combination with BNZ confers protection against Trypanosoma cruzi infection with a distinct cytokine response. Vaccine. 2026 Mar 19; 76:128296.
    View in: PubMed
    Score: 0.014
  72. Vaccination with recombinant aspartic hemoglobinase reduces parasite load and blood loss after hookworm infection in dogs. PLoS Med. 2005 Oct; 2(10):e295.
    View in: PubMed
    Score: 0.014
  73. Biochemical characterization and vaccine potential of a heme-binding glutathione transferase from the adult hookworm Ancylostoma caninum. Infect Immun. 2005 Oct; 73(10):6903-11.
    View in: PubMed
    Score: 0.014
  74. Expression of the Necator americanus hookworm larval antigen Na-ASP-2 in Pichia pastoris and purification of the recombinant protein for use in human clinical trials. Vaccine. 2005 Sep 15; 23(39):4754-64.
    View in: PubMed
    Score: 0.014
  75. Antibodies against a secreted protein from hookworm larvae reduce the intensity of hookworm infection in humans and vaccinated laboratory animals. FASEB J. 2005 Oct; 19(12):1743-5.
    View in: PubMed
    Score: 0.013
  76. Host cytokine production, lymphoproliferation, and antibody responses during the course of Ancylostoma ceylanicum infection in the Golden Syrian hamster. Infect Immun. 2005 Jun; 73(6):3402-7.
    View in: PubMed
    Score: 0.013
  77. Effect of combining the larval antigens Ancylostoma secreted protein 2 (ASP-2) and metalloprotease 1 (MTP-1) in protecting hamsters against hookworm infection and disease caused by Ancylostoma ceylanicum. Vaccine. 2005 May 02; 23(24):3123-30.
    View in: PubMed
    Score: 0.013
  78. Characteristic profiling of CHO-cell expressed MERS-CoV RBD-Fc. Int J Biol Macromol. 2025 Jun; 311(Pt 2):143678.
    View in: PubMed
    Score: 0.013
  79. Different responses involving Tfh cells delay parasite-specific antibody production in Trypanosoma cruzi acute experimental models. Front Immunol. 2025; 16:1487317.
    View in: PubMed
    Score: 0.013
  80. Crystallization and preliminary X-ray analysis of Na-ASP-1, a multi-domain pathogenesis-related-1 protein from the human hookworm parasite Necator americanus. Acta Crystallogr Sect F Struct Biol Cryst Commun. 2005 Apr 01; 61(Pt 4):391-4.
    View in: PubMed
    Score: 0.013
  81. A Honduran Prevalence Study on Soil-Transmitted Helminths Highlights Serological Antibodies to Tm-WAP49 as a Diagnostic Marker for Exposure to Human Trichuriasis. Am J Trop Med Hyg. 2025 May 07; 112(5):1017-1025.
    View in: PubMed
    Score: 0.013
  82. X-ray structure of Na-ASP-2, a pathogenesis-related-1 protein from the nematode parasite, Necator americanus, and a vaccine antigen for human hookworm infection. J Mol Biol. 2005 Feb 25; 346(3):801-14.
    View in: PubMed
    Score: 0.013
  83. Altering the intracellular trafficking of Necator americanus GST-1 antigen yields novel hookworm mRNA vaccine candidates. PLoS Negl Trop Dis. 2025 Jan; 19(1):e0012809.
    View in: PubMed
    Score: 0.013
  84. Helminth infections of children: prospects for control. Adv Exp Med Biol. 2005; 568:135-44.
    View in: PubMed
    Score: 0.013
  85. Randomized, observer-blind, controlled Phase 1 study of the safety and immunogenicity of the Na-GST-1/Alhydrogel hookworm vaccine with or without a CpG ODN adjuvant in hookworm-na?ve adults. PLoS Negl Trop Dis. 2024 Dec; 18(12):e0012788.
    View in: PubMed
    Score: 0.013
  86. Immunopeptidomic MHC-I profiling and immunogenicity testing identifies Tcj2 as a new Chagas disease mRNA vaccine candidate. PLoS Pathog. 2024 Dec; 20(12):e1012764.
    View in: PubMed
    Score: 0.013
  87. Optimizing immunogenicity and product presentation of a SARS-CoV-2 subunit vaccine composition: effects of delivery route, heterologous regimens with self-amplifying RNA vaccines, and lyophilization. Front Immunol. 2024; 15:1480976.
    View in: PubMed
    Score: 0.013
  88. Hookworm infection. N Engl J Med. 2004 Aug 19; 351(8):799-807.
    View in: PubMed
    Score: 0.013
  89. Ac-SAA-1, an immunodominant 16 kDa surface-associated antigen of infective larvae and adults of Ancylostoma caninum. Int J Parasitol. 2004 Aug; 34(9):1037-45.
    View in: PubMed
    Score: 0.013
  90. Parasitic Contamination of Soil in the Southern United States. Am J Trop Med Hyg. 2024 Sep 04; 111(3):506-514.
    View in: PubMed
    Score: 0.013
  91. Vaccine value profile for schistosomiasis. Vaccine. 2025 Oct 03; 64:126020.
    View in: PubMed
    Score: 0.013
  92. Vaccination of dogs with a recombinant cysteine protease from the intestine of canine hookworms diminishes the fecundity and growth of worms. J Infect Dis. 2004 May 15; 189(10):1952-61.
    View in: PubMed
    Score: 0.012
  93. Harnessing RNA Technology to Advance Therapeutic Vaccine Antigens against Chagas Disease. ACS Appl Mater Interfaces. 2024 Apr 03; 16(13):15832-15846.
    View in: PubMed
    Score: 0.012
  94. Safety and immunogenicity of the co-administered Na-APR-1 and Na-GST-1 hookworm vaccines in school-aged children in Gabon: a randomised, controlled, observer-blind, phase 1, dose-escalation trial. Lancet Infect Dis. 2024 07; 24(7):760-774.
    View in: PubMed
    Score: 0.012
  95. Environmental Detection of Parasites in the Marginalized Paiute Reservations Compared to a Nearby Area. Am J Trop Med Hyg. 2024 Mar 06; 110(3):457-459.
    View in: PubMed
    Score: 0.012
  96. Cloning, yeast expression, isolation, and vaccine testing of recombinant Ancylostoma-secreted protein (ASP)-1 and ASP-2 from Ancylostoma ceylanicum. J Infect Dis. 2004 Mar 01; 189(5):919-29.
    View in: PubMed
    Score: 0.012
  97. Human hookworm infection in the 21st century. Adv Parasitol. 2004; 58:197-288.
    View in: PubMed
    Score: 0.012
  98. The impact of vaccine-linked chemotherapy on liver health in a mouse model of chronic Trypanosoma cruzi infection. PLoS Negl Trop Dis. 2023 11; 17(11):e0011519.
    View in: PubMed
    Score: 0.012
  99. Localized cardiac small molecule trajectories and persistent chemical sequelae in experimental Chagas disease. Nat Commun. 2023 10 25; 14(1):6769.
    View in: PubMed
    Score: 0.012
  100. Progress in the development of a recombinant vaccine for human hookworm disease: the Human Hookworm Vaccine Initiative. Int J Parasitol. 2003 Sep 30; 33(11):1245-58.
    View in: PubMed
    Score: 0.012
  101. Molecular characterisation of the Ancylostoma-secreted protein family from the adult stage of Ancylostoma caninum. Int J Parasitol. 2003 Aug; 33(9):897-907.
    View in: PubMed
    Score: 0.012
  102. Effect of vaccination with a recombinant fusion protein encoding an astacinlike metalloprotease (MTP-1) secreted by host-stimulated Ancylostoma caninum third-stage infective larvae. J Parasitol. 2003 Aug; 89(4):853-5.
    View in: PubMed
    Score: 0.012
  103. Development of chimeric protein as a multivalent vaccine for human Kinetoplastid infections: Chagas disease and leishmaniasis. Vaccine. 2023 08 23; 41(37):5400-5411.
    View in: PubMed
    Score: 0.012
  104. Microbiome Alterations Driven by Trypanosoma cruzi Infection in Two Disjunctive Murine Models. Microbiol Spectr. 2023 06 15; 11(3):e0019923.
    View in: PubMed
    Score: 0.012
  105. An epidemiological study of ancylostomiasis in a rural area of Kanpur district Uttar Pradesh, India. Indian J Public Health. 2003 Apr-Jun; 47(2):53-60.
    View in: PubMed
    Score: 0.011
  106. A randomized, controlled Phase 1b trial of the Sm-TSP-2 Vaccine for intestinal schistosomiasis in healthy Brazilian adults living in an endemic area. PLoS Negl Trop Dis. 2023 03; 17(3):e0011236.
    View in: PubMed
    Score: 0.011
  107. Ac-FAR-1, a 20 kDa fatty acid- and retinol-binding protein secreted by adult Ancylostoma caninum hookworms: gene transcription pattern, ligand binding properties and structural characterisation. Mol Biochem Parasitol. 2003 Jan; 126(1):63-71.
    View in: PubMed
    Score: 0.011
  108. [Prokaryotic expression and characterization of an antigenic gene of adult Trichinella spiralis]. Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi. 2003; 21(1):16-9.
    View in: PubMed
    Score: 0.011
  109. Vaxi-DL: An Artificial Intelligence-Enabled Platform for Vaccine Development. Methods Mol Biol. 2023; 2673:305-316.
    View in: PubMed
    Score: 0.011
  110. Emerging patterns of hookworm infection: influence of aging on the intensity of Necator infection in Hainan Province, People's Republic of China. Clin Infect Dis. 2002 Dec 01; 35(11):1336-44.
    View in: PubMed
    Score: 0.011
  111. A novel multi-epitope recombinant protein elicits an antigen-specific CD8+?T cells response in Trypanosoma cruzi-infected mice. Vaccine. 2022 10 26; 40(45):6445-6449.
    View in: PubMed
    Score: 0.011
  112. Investigation of urinary metabolomics in a phase I hookworm vaccine trial in Gabon. PLoS One. 2022; 17(9):e0275013.
    View in: PubMed
    Score: 0.011
  113. Safety and immunogenicity of the Na-APR-1 hookworm vaccine in infection-na?ve adults. Vaccine. 2022 10 06; 40(42):6084-6092.
    View in: PubMed
    Score: 0.011
  114. Vaccine-linked chemotherapy with a low dose of benznidazole plus a bivalent recombinant protein vaccine prevents the development of cardiac fibrosis caused by Trypanosoma cruzi in chronically-infected BALB/c mice. PLoS Negl Trop Dis. 2022 09; 16(9):e0010258.
    View in: PubMed
    Score: 0.011
  115. Albendazole-soybean oil emulsion for the treatment of human cystic echinococcosis: evaluation of bioavailability and bioequivalence. Acta Trop. 2002 Aug; 83(2):177-81.
    View in: PubMed
    Score: 0.011
  116. Effect of vaccinations with recombinant fusion proteins on Ancylostoma caninum habitat selection in the canine intestine. J Parasitol. 2002 Aug; 88(4):684-90.
    View in: PubMed
    Score: 0.011
  117. Receptor-binding domain recombinant protein on alum-CpG induces broad protection against SARS-CoV-2 variants of concern. Vaccine. 2022 06 09; 40(26):3655-3663.
    View in: PubMed
    Score: 0.011
  118. Advancing a Human Onchocerciasis Vaccine From Antigen Discovery to Efficacy Studies Against Natural Infection of Cattle With Onchocerca ochengi. Front Cell Infect Microbiol. 2022; 12:869039.
    View in: PubMed
    Score: 0.011
  119. Augmented bioavailability and cysticidal activity of albendazole reformulated in soybean emulsion in mice infected with Echinococcus granulosus or Echinococcus multilocularis. Acta Trop. 2002 Apr; 82(1):77-84.
    View in: PubMed
    Score: 0.011
  120. Vaxi-DL: A web-based deep learning server to identify potential vaccine candidates. Comput Biol Med. 2022 06; 145:105401.
    View in: PubMed
    Score: 0.011
  121. Molecular cloning and purification of Ac-TMP, a developmentally regulated putative tissue inhibitor of metalloprotease released in relative abundance by adult Ancylostoma hookworms. Am J Trop Med Hyg. 2002 Mar; 66(3):238-44.
    View in: PubMed
    Score: 0.011
  122. An aluminum hydroxide:CpG adjuvant enhances protection elicited by a SARS-CoV-2 receptor binding domain vaccine in aged mice. Sci Transl Med. 2022 Jan 26; 14(629):eabj5305.
    View in: PubMed
    Score: 0.011
  123. Molecular cloning and characterization of Ac-mep-1, a developmentally regulated gut luminal metalloendopeptidase from adult Ancylostoma caninum hookworms. Mol Biochem Parasitol. 2002 Jan; 119(1):107-16.
    View in: PubMed
    Score: 0.011
  124. ASCVac-1, a Multi-Peptide Chimeric Vaccine, Protects Mice Against Ascaris suum Infection. Front Immunol. 2021; 12:788185.
    View in: PubMed
    Score: 0.010
  125. Yeast-expressed recombinant SARS-CoV-2 receptor binding domain RBD203-N1 as a COVID-19 protein vaccine candidate. Protein Expr Purif. 2022 02; 190:106003.
    View in: PubMed
    Score: 0.010
  126. Characterization of T cell responses to co-administered hookworm vaccine candidates Na-GST-1 and Na-APR-1 in healthy adults in Gabon. PLoS Negl Trop Dis. 2021 10; 15(10):e0009732.
    View in: PubMed
    Score: 0.010
  127. Location and expression kinetics of Tc24 in different life stages of Trypanosoma cruzi. PLoS Negl Trop Dis. 2021 09; 15(9):e0009689.
    View in: PubMed
    Score: 0.010
  128. Signal Transducer and Activator of Transcription-3 Modulation of Cardiac Pathology in Chronic Chagasic Cardiomyopathy. Front Cell Infect Microbiol. 2021; 11:708325.
    View in: PubMed
    Score: 0.010
  129. Epidemiology of Necator americanus hookworm infections in Xiulongkan Village, Hainan Province, China: high prevalence and intensity among middle-aged and elderly residents. J Parasitol. 2001 Aug; 87(4):739-43.
    View in: PubMed
    Score: 0.010
  130. A yeast expressed RBD-based SARS-CoV-2 vaccine formulated with 3M-052-alum adjuvant promotes protective efficacy in non-human primates. Sci Immunol. 2021 07 15; 6(61).
    View in: PubMed
    Score: 0.010
  131. Process development and scale-up optimization of the SARS-CoV-2 receptor binding domain-based vaccine candidate, RBD219-N1C1. Appl Microbiol Biotechnol. 2021 May; 105(10):4153-4165.
    View in: PubMed
    Score: 0.010
  132. SARS-CoV-2 RBD219-N1C1: A yeast-expressed SARS-CoV-2 recombinant receptor-binding domain candidate vaccine stimulates virus neutralizing antibodies and T-cell immunity in mice. Hum Vaccin Immunother. 2021 08 03; 17(8):2356-2366.
    View in: PubMed
    Score: 0.010
  133. Alterations to the Cardiac Metabolome Induced by Chronic T. cruzi Infection Relate to the Degree of Cardiac Pathology. ACS Infect Dis. 2021 06 11; 7(6):1638-1649.
    View in: PubMed
    Score: 0.010
  134. Environmental exposure to Toxocara as a possible risk factor for asthma: a clinic-based case-control study. Clin Infect Dis. 2001 Apr 01; 32(7):E111-6.
    View in: PubMed
    Score: 0.010
  135. Vaccine-linked chemotherapy induces IL-17 production and reduces cardiac pathology during acute Trypanosoma cruzi infection. Sci Rep. 2021 02 05; 11(1):3222.
    View in: PubMed
    Score: 0.010
  136. [Studies on immunological reaction of the antiserum of recombinant secreted protein from Ancylostoma caninum]. Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi. 2001; 19(3):166-8.
    View in: PubMed
    Score: 0.010
  137. Vaccination with chimeric protein induces protection in murine model against ascariasis. Vaccine. 2021 01 08; 39(2):394-401.
    View in: PubMed
    Score: 0.010
  138. Maternal Hookworm Infection and Its Effects on Maternal Health: A Systematic Review and Meta-Analysis. Am J Trop Med Hyg. 2020 11; 103(5):1958-1968.
    View in: PubMed
    Score: 0.010
  139. Host Immunity and Inflammation to Pulmonary Helminth Infections. Front Immunol. 2020; 11:594520.
    View in: PubMed
    Score: 0.010
  140. Prospects for a safe COVID-19 vaccine. Sci Transl Med. 2020 11 04; 12(568).
    View in: PubMed
    Score: 0.010
  141. Yeast-expressed SARS-CoV recombinant receptor-binding domain (RBD219-N1) formulated with aluminum hydroxide induces protective immunity and reduces immune enhancement. Vaccine. 2020 11 03; 38(47):7533-7541.
    View in: PubMed
    Score: 0.010
  142. Safety and immunogenicity of co-administered hookworm vaccine candidates Na-GST-1 and Na-APR-1 in Gabonese adults: a randomised, controlled, double-blind, phase 1 dose-escalation trial. Lancet Infect Dis. 2021 02; 21(2):275-285.
    View in: PubMed
    Score: 0.010
  143. A scalable and reproducible manufacturing process for Phlebotomus papatasi salivary protein PpSP15, a vaccine candidate for leishmaniasis. Protein Expr Purif. 2021 01; 177:105750.
    View in: PubMed
    Score: 0.010
  144. TLR4 agonist protects against Trypanosoma cruzi acute lethal infection by decreasing cardiac parasite burdens. Parasite Immunol. 2020 10; 42(10):e12769.
    View in: PubMed
    Score: 0.009
  145. Mebendazole and albendazole treatment of geohelminth infections in children and pregnant women. Pediatr Infect Dis J. 2000 Jul; 19(7):659-60.
    View in: PubMed
    Score: 0.009
  146. Safety and immunogenicity of a recombinant vaccine against Trypanosoma cruzi in Rhesus macaques. Vaccine. 2020 06 15; 38(29):4584-4591.
    View in: PubMed
    Score: 0.009
  147. Toxocara?species environmental contamination of public spaces in New York City. PLoS Negl Trop Dis. 2020 05; 14(5):e0008249.
    View in: PubMed
    Score: 0.009
  148. Global and regional seroprevalence estimates for human toxocariasis: A call for action. Adv Parasitol. 2020; 109:275-290.
    View in: PubMed
    Score: 0.009
  149. Global prevalence of Toxocara infection in cats. Adv Parasitol. 2020; 109:615-639.
    View in: PubMed
    Score: 0.009
  150. Reproductive Outcomes in Rhesus Macaques (Macaca mulatta) with Naturally-acquired Trypanosoma cruzi Infection. Comp Med. 2020 04 01; 70(2):152-159.
    View in: PubMed
    Score: 0.009
  151. Global prevalence of Toxocara infection in dogs. Adv Parasitol. 2020; 109:561-583.
    View in: PubMed
    Score: 0.009
  152. Process Characterization and Biophysical Analysis for a Yeast-Expressed Phlebotomus papatasi Salivary Protein (PpSP15) as?a Leishmania Vaccine Candidate. J Pharm Sci. 2020 05; 109(5):1673-1680.
    View in: PubMed
    Score: 0.009
  153. Protective immunity elicited by the nematode-conserved As37 recombinant protein against Ascaris suum infection. PLoS Negl Trop Dis. 2020 02; 14(2):e0008057.
    View in: PubMed
    Score: 0.009
  154. Hookworm burden reductions in BALB/c mice vaccinated with recombinant Ancylostoma secreted proteins (ASPs) from Ancylostoma duodenale, Ancylostoma caninum and Necator americanus. Vaccine. 2000 Jan 06; 18(11-12):1096-102.
    View in: PubMed
    Score: 0.009
  155. Construction and analysis of cDNA library of Necator americanus third stage larvae. Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi. 2000; 18(1):26-8.
    View in: PubMed
    Score: 0.009
  156. Seroprevalence estimates for toxocariasis in people worldwide: A?systematic review and meta-analysis. PLoS Negl Trop Dis. 2019 12; 13(12):e0007809.
    View in: PubMed
    Score: 0.009
  157. Length of protection by murine vaccination with living infective third-stage hookworm larvae. Chin Med J (Engl). 1999 Dec; 112(12):1129-32.
    View in: PubMed
    Score: 0.009
  158. Improved Biomarker and Imaging Analysis for Characterizing Progressive Cardiac Fibrosis in a Mouse Model of Chronic Chagasic Cardiomyopathy. J Am Heart Assoc. 2019 11 19; 8(22):e013365.
    View in: PubMed
    Score: 0.009
  159. Antibody-dependent reductions in mouse hookworm burden after vaccination with Ancylostoma caninum secreted protein 1. J Infect Dis. 1999 Nov; 180(5):1674-81.
    View in: PubMed
    Score: 0.009
  160. Cutaneous and subcutaneous mast cell and eosinophil responses after challenge in mice vaccinated with living infective third-stage hookworm larvae. Chin Med J (Engl). 1999 Nov; 112(11):1020-3.
    View in: PubMed
    Score: 0.009
  161. Experimental approaches to the development of a recombinant hookworm vaccine. Immunol Rev. 1999 Oct; 171:163-71.
    View in: PubMed
    Score: 0.009
  162. Antibody responses against the vaccine antigens Ov-103 and Ov-RAL-2 are associated with protective immunity to Onchocerca volvulus infection in both mice and humans. PLoS Negl Trop Dis. 2019 09; 13(9):e0007730.
    View in: PubMed
    Score: 0.009
  163. A phase 1 study of the safety, reactogenicity, and immunogenicity of a Schistosoma mansoni vaccine with or without glucopyranosyl lipid A aqueous formulation (GLA-AF) in healthy adults from a non-endemic area. Vaccine. 2019 10 08; 37(43):6500-6509.
    View in: PubMed
    Score: 0.009
  164. Epidemiology of hookworm infection in Itagua, Paraguay: a cross sectional study. Mem Inst Oswaldo Cruz. 1999 Sep-Oct; 94(5):583-6.
    View in: PubMed
    Score: 0.009
  165. A therapeutic vaccine prototype induces protective immunity and reduces cardiac fibrosis in a mouse model of chronic Trypanosoma cruzi infection. PLoS Negl Trop Dis. 2019 05; 13(5):e0007413.
    View in: PubMed
    Score: 0.009
  166. Ancylostoma secreted protein 2: cloning and characterization of a second member of a family of nematode secreted proteins from Ancylostoma caninum. Mol Biochem Parasitol. 1999 Apr 30; 99(2):149-65.
    View in: PubMed
    Score: 0.009
  167. Enzyme-linked immunoelectrotransfer blotting analysis of human serologic responses to infective hookworm larval antigen. Chin Med J (Engl). 1999 Mar; 112(3):249-50.
    View in: PubMed
    Score: 0.009
  168. Venezuela's humanitarian crisis, resurgence of vector-borne diseases, and implications for spillover in the region. Lancet Infect Dis. 2019 05; 19(5):e149-e161.
    View in: PubMed
    Score: 0.009
  169. Ancylostoma secreted protein 1 (ASP-1) homologues in human hookworms. Mol Biochem Parasitol. 1999 Jan 05; 98(1):143-9.
    View in: PubMed
    Score: 0.009
  170. [Sequencing of cytochrome C oxidase 1 gene of Ancylostoma duodenale and Necator americanus]. Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi. 1999; 17(2):81-3.
    View in: PubMed
    Score: 0.009
  171. Ascaris Larval Infection and Lung Invasion Directly Induce Severe Allergic Airway Disease in Mice. Infect Immun. 2018 12; 86(12).
    View in: PubMed
    Score: 0.008
  172. IgG Induced by Vaccination With Ascaris suum Extracts Is Protective Against Infection. Front Immunol. 2018; 9:2535.
    View in: PubMed
    Score: 0.008
  173. Ligand binding properties of two Brugia malayi fatty acid and retinol (FAR) binding proteins and their vaccine efficacies against challenge infection in gerbils. PLoS Negl Trop Dis. 2018 10; 12(10):e0006772.
    View in: PubMed
    Score: 0.008
  174. Covalent vaccination with Trypanosoma cruzi Tc24 induces catalytic antibody production. Parasite Immunol. 2018 Nov; 40(11):e12585.
    View in: PubMed
    Score: 0.008
  175. Production of recombinant TSA-1 and evaluation of its potential for the immuno-therapeutic control of Trypanosoma cruzi infection in mice. Hum Vaccin Immunother. 2019; 15(1):210-219.
    View in: PubMed
    Score: 0.008
  176. Epidemiology of human intestinal nematode infections in Wujiang and Pizhou counties, Jiangsu Province, China. Southeast Asian J Trop Med Public Health. 1998 Sep; 29(3):605-10.
    View in: PubMed
    Score: 0.008
  177. Cutaneous and subcutaneous granulomata formation in mice immunized and challenged with third-stage infective hookworm (Ancylostoma caninum) larvae. Acta Trop. 1998 Jun; 69(3):229-38.
    View in: PubMed
    Score: 0.008
  178. A novel blood-feeding detoxification pathway in Nippostrongylus brasiliensis L3 reveals a potential checkpoint for arresting hookworm development. PLoS Pathog. 2018 03; 14(3):e1006931.
    View in: PubMed
    Score: 0.008
  179. Progress in the development of a vaccine against schistosomiasis in China. Int J Infect Dis. 1998 Jan-Mar; 2(3):176-80.
    View in: PubMed
    Score: 0.008
  180. Protective immunity in mice elicited by living infective third-stage hookworm larvae (Shanghai strain of Ancylostoma caninum). Chin Med J (Engl). 1998 Jan; 111(1):43-8.
    View in: PubMed
    Score: 0.008
  181. Human Intestinal Parasite Burden and Poor Sanitation in Rural Alabama. Am J Trop Med Hyg. 2017 Nov; 97(5):1623-1628.
    View in: PubMed
    Score: 0.008
  182. Vaccines for hookworm infection. Pediatr Infect Dis J. 1997 Oct; 16(10):935-40.
    View in: PubMed
    Score: 0.008
  183. Onchocerca volvulus: The Road from Basic Biology to a Vaccine. Trends Parasitol. 2018 01; 34(1):64-79.
    View in: PubMed
    Score: 0.008
  184. Genetic Adjuvantation of a Cell-Based Therapeutic Vaccine for Amelioration of Chagasic Cardiomyopathy. Infect Immun. 2017 09; 85(9).
    View in: PubMed
    Score: 0.008
  185. Human toxocariasis. Lancet Infect Dis. 2018 01; 18(1):e14-e24.
    View in: PubMed
    Score: 0.008
  186. The Global State of Helminth Control and Elimination in Children. Pediatr Clin North Am. 2017 08; 64(4):867-877.
    View in: PubMed
    Score: 0.008
  187. Yeast-expressed recombinant As16 protects mice against Ascaris suum infection through induction of a Th2-skewed immune response. PLoS Negl Trop Dis. 2017 Jul; 11(7):e0005769.
    View in: PubMed
    Score: 0.008
  188. Emerging and reemerging helminthiases and the public health of China. Emerg Infect Dis. 1997 Jul-Sep; 3(3):303-10.
    View in: PubMed
    Score: 0.008
  189. Mutations to Cysteine Residues in the Trypanosoma cruzi B-Cell Superantigen Tc24 Diminish Susceptibility to IgM-Mediated Hydrolysis. J Parasitol. 2017 10; 103(5):579-583.
    View in: PubMed
    Score: 0.008
  190. Safety and immunogenicity of the Na-GST-1 hookworm vaccine in Brazilian and American adults. PLoS Negl Trop Dis. 2017 05; 11(5):e0005574.
    View in: PubMed
    Score: 0.008
  191. Structure of SALO, a leishmaniasis vaccine candidate from the sand fly Lutzomyia longipalpis. PLoS Negl Trop Dis. 2017 03; 11(3):e0005374.
    View in: PubMed
    Score: 0.008
  192. Advances in neglected tropical disease vaccines: Developing relative potency and functional assays for the Na-GST-1/Alhydrogel hookworm vaccine. PLoS Negl Trop Dis. 2017 02; 11(2):e0005385.
    View in: PubMed
    Score: 0.007
  193. Hookworm infection. Nat Rev Dis Primers. 2016 12 08; 2:16088.
    View in: PubMed
    Score: 0.007
  194. Vaccination with alum-precipitated recombinant Ancylostoma-secreted protein 1 protects mice against challenge infections with infective hookworm (Ancylostoma caninum) larvae. J Infect Dis. 1996 Dec; 174(6):1380-3.
    View in: PubMed
    Score: 0.007
  195. Hookworm recombinant protein promotes regulatory T cell responses that suppress experimental asthma. Sci Transl Med. 2016 10 26; 8(362):362ra143.
    View in: PubMed
    Score: 0.007
  196. Expression, purification, immunogenicity and protective efficacy of a recombinant nucleoside hydrolase from Leishmania donovani, a vaccine candidate for preventing cutaneous leishmaniasis. Protein Expr Purif. 2017 02; 130:129-136.
    View in: PubMed
    Score: 0.007
  197. Molecular approaches to vaccinating against hookworm disease. Pediatr Res. 1996 Oct; 40(4):515-21.
    View in: PubMed
    Score: 0.007
  198. Hookworm: developmental biology of the infectious process. Curr Opin Genet Dev. 1996 Oct; 6(5):618-23.
    View in: PubMed
    Score: 0.007
  199. Ancylostoma caninum anticoagulant peptide: cloning by PCR and expression of soluble, active protein in E. coli. Mol Biochem Parasitol. 1996 Sep; 80(1):113-7.
    View in: PubMed
    Score: 0.007
  200. The Immunomodulatory Role of Adjuvants in Vaccines Formulated with the Recombinant Antigens Ov-103 and Ov-RAL-2 against Onchocerca volvulus in Mice. PLoS Negl Trop Dis. 2016 07; 10(7):e0004797.
    View in: PubMed
    Score: 0.007
  201. Vaccination of Gerbils with Bm-103 and Bm-RAL-2 Concurrently or as a Fusion Protein Confers Consistent and Improved Protection against Brugia malayi Infection. PLoS Negl Trop Dis. 2016 Apr; 10(4):e0004586.
    View in: PubMed
    Score: 0.007
  202. Advancing a vaccine to prevent human schistosomiasis. Vaccine. 2016 06 03; 34(26):2988-2991.
    View in: PubMed
    Score: 0.007
  203. Cloning and characterization of Ancylostoma-secreted protein. A novel protein associated with the transition to parasitism by infective hookworm larvae. J Biol Chem. 1996 Mar 22; 271(12):6672-8.
    View in: PubMed
    Score: 0.007
  204. Status of vaccine research and development of vaccines for leishmaniasis. Vaccine. 2016 06 03; 34(26):2992-2995.
    View in: PubMed
    Score: 0.007
  205. Impact of vectorborne parasitic neglected tropical diseases on child health. Arch Dis Child. 2016 07; 101(7):640-7.
    View in: PubMed
    Score: 0.007
  206. A therapeutic nanoparticle vaccine against Trypanosoma cruzi in a BALB/c mouse model of Chagas disease. Hum Vaccin Immunother. 2016 04 02; 12(4):976-87.
    View in: PubMed
    Score: 0.007
  207. Expression and purification of an engineered, yeast-expressed Leishmania donovani nucleoside hydrolase with immunogenic properties. Hum Vaccin Immunother. 2016 07 02; 12(7):1707-20.
    View in: PubMed
    Score: 0.007
  208. Identification and Characterization of the Trypanosoma cruzi B-cell Superantigen Tc24. Am J Trop Med Hyg. 2016 Jan; 94(1):114-121.
    View in: PubMed
    Score: 0.007
  209. Identification of immunodominant antigens for the laboratory diagnosis of toxocariasis. Trop Med Int Health. 2015 Dec; 20(12):1787-96.
    View in: PubMed
    Score: 0.007
  210. Mesoamerican nephropathy: a neglected tropical disease with an infectious etiology? Microbes Infect. 2015 Oct; 17(10):671-5.
    View in: PubMed
    Score: 0.007
  211. Expression, purification, immunogenicity, and protective efficacy of a recombinant Tc24 antigen as a vaccine against Trypanosoma cruzi infection in mice. Vaccine. 2015 Aug 26; 33(36):4505-12.
    View in: PubMed
    Score: 0.007
  212. Ancylostoma caninum anticoagulant peptide: a hookworm-derived inhibitor of human coagulation factor Xa. Proc Natl Acad Sci U S A. 1995 Jun 20; 92(13):6152-6.
    View in: PubMed
    Score: 0.007
  213. Molecular pathobiology of hookworm infection. Infect Agents Dis. 1995 Jun; 4(2):71-5.
    View in: PubMed
    Score: 0.007
  214. Hookworm infection. Sci Am. 1995 Jun; 272(6):68-74.
    View in: PubMed
    Score: 0.007
  215. Ancylostoma caninum: metalloprotease release coincides with activation of infective larvae in vitro. Exp Parasitol. 1995 Mar; 80(2):205-11.
    View in: PubMed
    Score: 0.007
  216. Expression, purification, and characterization of the Necator americanus aspartic protease-1 (Na-APR-1 (M74)) antigen, a component of the bivalent human hookworm vaccine. Hum Vaccin Immunother. 2015; 11(6):1474-88.
    View in: PubMed
    Score: 0.006
  217. New tools for NTD vaccines: A case study of quality control assays for product development of the human hookworm vaccine Na-APR-1M74. Hum Vaccin Immunother. 2015; 11(5):1251-7.
    View in: PubMed
    Score: 0.006
  218. Cloning and characterization of a cDNA encoding the catalytic subunit of a cAMP-dependent protein kinase from Ancylostoma caninum third-stage infective larvae. Mol Biochem Parasitol. 1995 Jan; 69(1):127-30.
    View in: PubMed
    Score: 0.006
  219. Impact of Schistosoma mansoni on malaria transmission in Sub-Saharan Africa. PLoS Negl Trop Dis. 2014 Oct; 8(10):e3234.
    View in: PubMed
    Score: 0.006
  220. Hyaluronidases of the gastrointestinal invasive nematodes Ancylostoma caninum and Anisakis simplex: possible functions in the pathogenesis of human zoonoses. J Infect Dis. 1994 Oct; 170(4):918-26.
    View in: PubMed
    Score: 0.006
  221. Potential novel risk factors for autochthonous and sylvatic transmission of human Chagas disease in the United States. Parasit Vectors. 2014 Jul 04; 7:311.
    View in: PubMed
    Score: 0.006
  222. Vaccines to combat river blindness: expression, selection and formulation of vaccines against infection with Onchocerca volvulus in a mouse model. Int J Parasitol. 2014 Aug; 44(9):637-46.
    View in: PubMed
    Score: 0.006
  223. Kv1.3 channel-blocking immunomodulatory peptides from parasitic worms: implications for autoimmune diseases. FASEB J. 2014 Sep; 28(9):3952-64.
    View in: PubMed
    Score: 0.006
  224. Neglected parasitic infections in the United States: needs and opportunities. Am J Trop Med Hyg. 2014 May; 90(5):783-785.
    View in: PubMed
    Score: 0.006
  225. Genome of the human hookworm Necator americanus. Nat Genet. 2014 Mar; 46(3):261-269.
    View in: PubMed
    Score: 0.006
  226. Optimization and revision of the production process of the Necator americanus glutathione S-transferase 1 (Na-GST-1), the lead hookworm vaccine recombinant protein candidate. Hum Vaccin Immunother. 2014; 10(7):1914-25.
    View in: PubMed
    Score: 0.006
  227. Yeast-expressed recombinant protein of the receptor-binding domain in SARS-CoV spike protein with deglycosylated forms as a SARS vaccine candidate. Hum Vaccin Immunother. 2014; 10(3):648-58.
    View in: PubMed
    Score: 0.006
  228. Expression at a 20L scale and purification of the extracellular domain of the Schistosoma mansoni TSP-2 recombinant protein: a vaccine candidate for human intestinal schistosomiasis. Hum Vaccin Immunother. 2013 Nov; 9(11):2342-50.
    View in: PubMed
    Score: 0.006
  229. Biophysical and formulation studies of the Schistosoma mansoni TSP-2 extracellular domain recombinant protein, a lead vaccine candidate antigen for intestinal schistosomiasis. Hum Vaccin Immunother. 2013 Nov; 9(11):2351-61.
    View in: PubMed
    Score: 0.006
  230. Disseminated strongyloidiasis. Semin Neurol. 1993 Jun; 13(2):169-74.
    View in: PubMed
    Score: 0.006
  231. Visceral and ocular larva migrans. Semin Neurol. 1993 Jun; 13(2):175-9.
    View in: PubMed
    Score: 0.006
  232. Ancylostoma factor Xa inhibitor: partial purification and its identification as a major hookworm-derived anticoagulant in vitro. J Infect Dis. 1993 Jun; 167(6):1474-7.
    View in: PubMed
    Score: 0.006
  233. Accelerating the development of a therapeutic vaccine for human Chagas disease: rationale and prospects. Expert Rev Vaccines. 2012 Sep; 11(9):1043-55.
    View in: PubMed
    Score: 0.006
  234. Fusion of Na-ASP-2 with human immunoglobulin Fc? abrogates histamine release from basophils sensitized with anti-Na-ASP-2 IgE. Parasite Immunol. 2012 Aug-Sep; 34(8-9):404-11.
    View in: PubMed
    Score: 0.005
  235. Molecular mechanisms of hookworm disease: stealth, virulence, and vaccines. J Allergy Clin Immunol. 2012 Jul; 130(1):13-21.
    View in: PubMed
    Score: 0.005
  236. Generalized urticaria induced by the Na-ASP-2 hookworm vaccine: implications for the development of vaccines against helminths. J Allergy Clin Immunol. 2012 Jul; 130(1):169-76.e6.
    View in: PubMed
    Score: 0.005
  237. Advances in vaccines against neglected tropical diseases: enhancing physical stability of a recombinant hookworm vaccine through biophysical and formulation studies. Hum Vaccin Immunother. 2012 Jun; 8(6):765-76.
    View in: PubMed
    Score: 0.005
  238. Expression, purification, and molecular analysis of the Necator americanus glutathione S-transferase 1 (Na-GST-1): a production process developed for a lead candidate recombinant hookworm vaccine antigen. Protein Expr Purif. 2012 Jun; 83(2):145-51.
    View in: PubMed
    Score: 0.005
  239. Enhanced protective efficacy of a chimeric form of the schistosomiasis vaccine antigen Sm-TSP-2. PLoS Negl Trop Dis. 2012; 6(3):e1564.
    View in: PubMed
    Score: 0.005
  240. Hyaluronidase from infective Ancylostoma hookworm larvae and its possible function as a virulence factor in tissue invasion and in cutaneous larva migrans. Infect Immun. 1992 Mar; 60(3):1018-23.
    View in: PubMed
    Score: 0.005
  241. Expression, immunogenicity, histopathology, and potency of a mosquito-based malaria transmission-blocking recombinant vaccine. Infect Immun. 2012 Apr; 80(4):1606-14.
    View in: PubMed
    Score: 0.005
  242. A history of hookworm vaccine development. Hum Vaccin. 2011 Nov; 7(11):1234-44.
    View in: PubMed
    Score: 0.005
  243. Acquired hookworm immunity in the golden hamster (Mesocricetus auratus) elicited by living Necator americanus third-stage infective larvae. Exp Parasitol. 2012 Jan; 130(1):6-12.
    View in: PubMed
    Score: 0.005
  244. Inflammatory response to liver fluke Opisthorchis viverrini in mice depends on host master coregulator MTA1, a marker for parasite-induced cholangiocarcinoma in humans. Hepatology. 2011 Oct; 54(4):1388-97.
    View in: PubMed
    Score: 0.005
  245. The metastasis-associated protein-1 gene encodes a host permissive factor for schistosomiasis, a leading global cause of inflammation and cancer. Hepatology. 2011 Jul; 54(1):285-95.
    View in: PubMed
    Score: 0.005
  246. Selection and quantification of infection endpoints for trials of vaccines against intestinal helminths. Vaccine. 2011 May 09; 29(20):3686-94.
    View in: PubMed
    Score: 0.005
  247. Soil-transmitted helminths of humans in Southeast Asia--towards integrated control. Adv Parasitol. 2011; 74:231-65.
    View in: PubMed
    Score: 0.005
  248. Metalloproteases of infective Ancylostoma hookworm larvae and their possible functions in tissue invasion and ecdysis. Infect Immun. 1990 Dec; 58(12):3883-92.
    View in: PubMed
    Score: 0.005
  249. Potency testing for the experimental Na-GST-1 hookworm vaccine. Expert Rev Vaccines. 2010 Oct; 9(10):1219-30.
    View in: PubMed
    Score: 0.005
  250. The global atlas of helminth infection: mapping the way forward in neglected tropical disease control. PLoS Negl Trop Dis. 2010 Jul 27; 4(7):e779.
    View in: PubMed
    Score: 0.005
  251. Opisthorchiasis and Opisthorchis-associated cholangiocarcinoma in Thailand and Laos. Acta Trop. 2011 Sep; 120 Suppl 1:S158-68.
    View in: PubMed
    Score: 0.005
  252. Neutralizing antibodies to the hookworm hemoglobinase Na-APR-1: implications for a multivalent vaccine against hookworm infection and schistosomiasis. J Infect Dis. 2010 May 15; 201(10):1561-9.
    View in: PubMed
    Score: 0.005
  253. An enzymatically inactivated hemoglobinase from Necator americanus induces neutralizing antibodies against multiple hookworm species and protects dogs against heterologous hookworm infection. FASEB J. 2009 Sep; 23(9):3007-19.
    View in: PubMed
    Score: 0.004
  254. Proteolytic degradation of hemoglobin in the intestine of the human hookworm Necator americanus. J Infect Dis. 2009 Mar 15; 199(6):904-12.
    View in: PubMed
    Score: 0.004
  255. Modelling heterogeneity and the impact of chemotherapy and vaccination against human hookworm. J R Soc Interface. 2008 Nov 06; 5(28):1329-41.
    View in: PubMed
    Score: 0.004
  256. Hookworm-related anaemia among pregnant women: a systematic review. PLoS Negl Trop Dis. 2008 Sep 17; 2(9):e291.
    View in: PubMed
    Score: 0.004
  257. A family of cathepsin B cysteine proteases expressed in the gut of the human hookworm, Necator americanus. Mol Biochem Parasitol. 2008 Aug; 160(2):90-9.
    View in: PubMed
    Score: 0.004
  258. Epidemiology of plasmodium-helminth co-infection in Africa: populations at risk, potential impact on anemia, and prospects for combining control. Am J Trop Med Hyg. 2007 Dec; 77(6 Suppl):88-98.
    View in: PubMed
    Score: 0.004
  259. Repeatability of paired counts. Stat Med. 2007 Aug 30; 26(19):3566-77.
    View in: PubMed
    Score: 0.004
  260. Reduction of worm fecundity and canine host blood loss mediates protection against hookworm infection elicited by vaccination with recombinant Ac-16. Clin Vaccine Immunol. 2007 Mar; 14(3):281-7.
    View in: PubMed
    Score: 0.004
  261. Saturation of the secretory pathway by overexpression of a hookworm (Necator americanus) Protein (Na-ASP1). Methods Mol Biol. 2007; 389:65-76.
    View in: PubMed
    Score: 0.004
  262. The co-distribution of Plasmodium falciparum and hookworm among African schoolchildren. Malar J. 2006 Nov 03; 5:99.
    View in: PubMed
    Score: 0.004
  263. Age-related changes in hookworm infection, anaemia and iron deficiency in an area of high Necator americanus hookworm transmission in south-eastern Brazil. Trans R Soc Trop Med Hyg. 2007 Feb; 101(2):146-54.
    View in: PubMed
    Score: 0.004
  264. Protective immunity elicited by ultraviolet-irradiated third-stage infective hookworm (Necator americanus and Ancylostoma caninum) larvae in mice and hamsters. Southeast Asian J Trop Med Public Health. 2006 Sep; 37(5):885-95.
    View in: PubMed
    Score: 0.004
  265. Contrasting patterns in the small-scale heterogeneity of human helminth infections in urban and rural environments in Brazil. Int J Parasitol. 2006 Sep; 36(10-11):1143-51.
    View in: PubMed
    Score: 0.004
  266. Ancylostoma caninum MTP-1, an astacin-like metalloprotease secreted by infective hookworm larvae, is involved in tissue migration. Infect Immun. 2006 Feb; 74(2):961-7.
    View in: PubMed
    Score: 0.003
  267. Synergistic associations between hookworm and other helminth species in a rural community in Brazil. Trop Med Int Health. 2006 Jan; 11(1):56-64.
    View in: PubMed
    Score: 0.003
  268. Vaccines against blood-feeding nematodes of humans and livestock. Parasitology. 2006; 133 Suppl:S63-79.
    View in: PubMed
    Score: 0.003
  269. The impact of concurrent and treated Ancylostoma ceylanicum hookworm infections on the immunogenicity of a recombinant hookworm vaccine in hamsters. J Infect Dis. 2006 Jan 01; 193(1):155-62.
    View in: PubMed
    Score: 0.003
  270. Necator americanus: optimization of the golden hamster model for testing anthelmintic drugs. Exp Parasitol. 2005 Dec; 111(4):219-23.
    View in: PubMed
    Score: 0.003
  271. Vaccination with irradiated Ancylostoma caninum third stage larvae induces a Th2 protective response in dogs. Vaccine. 2006 Jan 23; 24(4):501-9.
    View in: PubMed
    Score: 0.003
  272. Isolation and characterization of a proteolytic enzyme from the adult hookworm Ancylostoma caninum. J Biol Chem. 1985 Jun 25; 260(12):7343-8.
    View in: PubMed
    Score: 0.003
  273. Immunogenicity of the hookworm Na-ASP-2 vaccine candidate: characterization of humoral and cellular responses after vaccination in the Sprague Dawley rat. Hum Vaccin. 2005 May-Jun; 1(3):123-8.
    View in: PubMed
    Score: 0.003
  274. A secreted protein from the human hookworm necator americanus binds selectively to NK cells and induces IFN-gamma production. J Immunol. 2004 Aug 15; 173(4):2699-704.
    View in: PubMed
    Score: 0.003
  275. A pore-forming haemolysin from the hookworm, Ancylostoma caninum. Int J Parasitol. 2004 Aug; 34(9):1029-35.
    View in: PubMed
    Score: 0.003
  276. A multi-enzyme cascade of hemoglobin proteolysis in the intestine of blood-feeding hookworms. J Biol Chem. 2004 Aug 20; 279(34):35950-7.
    View in: PubMed
    Score: 0.003
  277. Lipoprotein lipase suppression in 3T3-L1 cells by a haematoprotozoan-induced mediator from peritoneal exudate cells. Parasite Immunol. 1984 May; 6(3):203-9.
    View in: PubMed
    Score: 0.003
  278. Soil-transmitted helminth infections: updating the global picture. Trends Parasitol. 2003 Dec; 19(12):547-51.
    View in: PubMed
    Score: 0.003
  279. Necator americanus: maintenance through one hundred generations in golden hamsters (Mesocricetus auratus). II. Morphological development of the adult and its comparison with humans. Exp Parasitol. 2003 Nov-Dec; 105(3-4):192-200.
    View in: PubMed
    Score: 0.003
  280. Digestive proteases of blood-feeding nematodes. Trends Parasitol. 2003 Sep; 19(9):417-23.
    View in: PubMed
    Score: 0.003
  281. Secretion of a proteolytic anticoagulant by Ancylostoma hookworms. J Exp Med. 1983 May 01; 157(5):1594-603.
    View in: PubMed
    Score: 0.003
  282. Helminth vaccines: from mining genomic information for vaccine targets to systems used for protein expression. Int J Parasitol. 2003 May; 33(5-6):621-40.
    View in: PubMed
    Score: 0.003
  283. Necator americanus: maintenance through one hundred generations in golden hamsters (Mesocricetus auratus). I. Host sex-associated differences in hookworm burden and fecundity. Exp Parasitol. 2003 May-Jun; 104(1-2):62-6.
    View in: PubMed
    Score: 0.003
  284. Hookworm aspartic protease, Na-APR-2, cleaves human hemoglobin and serum proteins in a host-specific fashion. J Infect Dis. 2003 Feb 01; 187(3):484-94.
    View in: PubMed
    Score: 0.003
  285. Cleavage of hemoglobin by hookworm cathepsin D aspartic proteases and its potential contribution to host specificity. FASEB J. 2002 Sep; 16(11):1458-60.
    View in: PubMed
    Score: 0.003
  286. A developmentally regulated metalloprotease secreted by host-stimulated Ancylostoma caninum third-stage infective larvae is a member of the astacin family of proteases. Mol Biochem Parasitol. 2002 Apr 09; 120(2):291-6.
    View in: PubMed
    Score: 0.003
  287. Electron and light microscopy of neutrophil responses in mice vaccinated and challenged with third-stage infective hookworm (Ancylostoma caninum) larvae. Parasitol Int. 2001 Nov; 50(4):241-8.
    View in: PubMed
    Score: 0.003
  288. Artemether, an effective new agent for chemoprophylaxis against shistosomiasis in China: its in vivo effect on the biochemical metabolism of the Asian schistosome. Southeast Asian J Trop Med Public Health. 2000 Dec; 31(4):724-32.
    View in: PubMed
    Score: 0.002
  289. Epidemiology of human geohelminth infections (ascariasis, trichuriasis and necatoriasis) in Lushui and Puer Counties, Yunnan Province, China. Southeast Asian J Trop Med Public Health. 2000 Sep; 31(3):448-53.
    View in: PubMed
    Score: 0.002
  290. Variation between ASP-1 molecules from Ancylostoma caninum in China and the United States. J Parasitol. 2000 Feb; 86(1):181-5.
    View in: PubMed
    Score: 0.002
  291. A common muscarinic pathway for diapause recovery in the distantly related nematode species Caenorhabditis elegans and Ancylostoma caninum. Proc Natl Acad Sci U S A. 2000 Jan 04; 97(1):460-5.
    View in: PubMed
    Score: 0.002
  292. Epidemiology of human ancylostomiasis among rural villagers in Nanlin County (Zhongzhou village), Anhui Province, China: age-associated prevalence, intensity and hookworm species identification. Southeast Asian J Trop Med Public Health. 1999 Dec; 30(4):692-7.
    View in: PubMed
    Score: 0.002
  293. Epidemiology of human hookworm infections among adult villagers in Hejiang and Santai Counties, Sichuan Province, China. Acta Trop. 1999 Oct 15; 73(3):243-9.
    View in: PubMed
    Score: 0.002
  294. Histochemical alterations of infective third-stage hookworm larvae (L3) in vaccinated mice. Southeast Asian J Trop Med Public Health. 1999 Jun; 30(2):356-64.
    View in: PubMed
    Score: 0.002
  295. Electron and light microscopy of peritoneal cellular immune responses in mice vaccinated and challenged with third-stage infective hookworm (Ancylostoma caninum) larvae. Acta Trop. 1998 Sep 15; 71(2):155-67.
    View in: PubMed
    Score: 0.002
  296. Anticoagulant repertoire of the hookworm Ancylostoma caninum. Proc Natl Acad Sci U S A. 1996 Mar 05; 93(5):2149-54.
    View in: PubMed
    Score: 0.002
  297. Weight loss associated with an endotoxin-induced mediator from peritoneal macrophages: the role of cachectin (tumor necrosis factor). Immunol Lett. 1985; 11(3-4):173-7.
    View in: PubMed
    Score: 0.001
  298. Trypanosoma congolense: surface glycoproteins of two early bloodstream variants. III. Immunochemical characterization. Exp Parasitol. 1982 Feb; 53(1):1-10.
    View in: PubMed
    Score: 0.001
  299. Trypanosoma congolense: surface glycoproteins of two early bloodstream variants. II. Purification and partial chemical characterization. Exp Parasitol. 1981 Dec; 52(3):427-39.
    View in: PubMed
    Score: 0.001
  300. Trypanosoma congolense: surface glycoproteins of two early bloodstream variants. I. Production of a relapsing infection in rodents. Exp Parasitol. 1981 Oct; 52(2):210-8.
    View in: PubMed
    Score: 0.001
  301. Antigenic variation and the surface glycoproteins of Trypanosoma congolense. Fed Proc. 1981 Apr; 40(5):1434-9.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.